Navigation Links
Akaza Research to Present OpenClinica Electronic Data Capture Software at Partnerships in Clinical Trials 2010
Date:2/16/2010

Professional open source model demonstrates advantages in partnering with sponsors and CROs

Orlando, FL (PRWEB) February 16, 2010 -- Akaza Research is pleased to announce its participation in the upcoming 2010 Partnerships in Clinical Trials conference, April 12-14 in Orlando, Florida. The event is being held at the Orlando World Center Marriott Resort and is one of the premier worldwide events for clinical outsourcing and development.

At the event Akaza will be hosting an exhibit booth and presenting OpenClinica, its popular open source electronic data capture and clinical data management software. As the world’s most widely used open source EDC system, OpenClinica offers clinical trial sponsors and Contract Research Organizations (CROs) a uniquely flexible way to obtain an industrial strength electronic data capture system with the benefits of a professional open source model.

“Especially when it comes to partnerships, open source offers real advantages that just don’t exist in the proprietary world,” said Benjamin Baumann, Director of Business Development at Akaza Research, LLC. “For example, a CRO can exercise a much greater degree of control over how its EDC technology is implemented and serviced, delivering greater success to the customer and enabling greater cost efficiency.”

The professional open source model Akaza practices with OpenClinica is similar to that of other notable open source companies such RedHat, MySQL, and SugarCRM.

OpenClinica representatives will be available for discussions at Booth #363.

About OpenClinica®

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case report forms (eCRFs), and enables productive clinical trials management. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulator guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for free download from http://www.openclinica.org.

About Akaza Research®

Akaza Research, the leading provider of open source clinical trial software, is headquartered in Waltham, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the he world’s most popular open source clinical research software. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for all types of clinical research. Akaza Research provides OpenClinica support, training, hosting and other value added services to its customers worldwide. See www.akazaresearch.com.

###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3609044.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Akaza Research to Present OpenClinica 3.0 at Upcoming Clinical Research Conferences: SoCRA, SCDM
2. Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting
3. Akaza Research to Present OpenClinica at ACRP Global Conference & Exhibition
4. Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
5. 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
6. Dramatic changes in agriculture needed as world warms and grows, researchers say
7. NIH Director Francis Collins to Speak at National Press Club February 26 on A New Era of Quantum Leaps in Biomedical Research
8. European research initiative EUREKA presented at Research & Technology for the first time
9. endpoint Saves Money and Time for Medical Research Teams Through PULSE
10. Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps
11. Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Akaza Research to Present OpenClinica Electronic Data Capture Software at Partnerships in Clinical Trials 2010 
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
Breaking Biology Technology:
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):